首页> 外国专利> GLYCATION OF L-LYSINE TO LOWER BLOOD GLUCOSE AND TREAT COMPLICATIONS OF DIABETES

GLYCATION OF L-LYSINE TO LOWER BLOOD GLUCOSE AND TREAT COMPLICATIONS OF DIABETES

机译:L-赖氨酸糖化为低血糖和糖尿病的并发症

摘要

Control of blood glucose is a fundamental goal in the treatment of diabetes mellitus. Glycation of l-lysine can lower blood glucose and advanced glycation end product (AGE) free adducts can be excreted in the urine. Lysine, an inexpensive amino acid, can be administered orally or parentally, and can be incorporated into a stereocomplex matrix as a time released preparation. In patients who suffer from diabetes and concomitant renal insufficiency who cannot clear sufficient quantities of AGE free adducts enantiomeric mixtures of lysine will lower blood glucose and AGEs since d-lysine has been shown to decrease protein glycation and lower hemoglobin Alc. This invention is not intended to replace insulin or oral hypoglycemic agents but is does offer patients a low cost and probably safe complementary therapy for the treatment of diabetes mellitus. In addition to the treatment of diabetes and its complications, this invention could lower AGE burden and slow or ameliorate some of the consequences of aging.
机译:控制血糖是治疗糖尿病的基本目标。 l-赖氨酸的糖基化可以降低血糖,而晚期糖基化终产物(AGE)的游离加合物可以从尿中排出。赖氨酸是一种廉价的氨基酸,可以口服或非肠道给药,并且可以作为延时释放的制剂掺入立体复合物基质中。在患有糖尿病和伴随肾功能不全的患者中,不能清除足够量的AGE自由加合物的赖氨酸的对映异构体混合物会降低血糖和AGEs,因为已证明d-赖氨酸可降低蛋白质糖化和降低血红蛋白Alc。本发明无意替代胰岛素或口服降糖药,但确实为患者提供了一种低成本且可能是安全的辅助疗法,用于治疗糖尿病。除了治疗糖尿病及其并发症,本发明还可以降低AGE负担并减缓或改善衰老的某些后果。

著录项

  • 公开/公告号US2015182483A1

    专利类型

  • 公开/公告日2015-07-02

    原文格式PDF

  • 申请/专利权人 JOEL STEVEN GOLDBERG;

    申请/专利号US201414182011

  • 发明设计人 JOEL STEVEN GOLDBERG;

    申请日2014-02-17

  • 分类号A61K31/198;

  • 国家 US

  • 入库时间 2022-08-21 15:24:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号